CT HB05366 | 2020 | General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 27 2020 - 25% progression, died in chamber
Action: 2020-03-11 - Filed with Legislative Commissioners' Office
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 27 2020 - 25% progression, died in chamber
Action: 2020-03-11 - Filed with Legislative Commissioners' Office
Text: Latest bill text (Introduced) [PDF]
Summary
To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.
Title
An Act Concerning The Cost Of Prescription Drugs.
Sponsors
Roll Calls
2020-03-11 - Joint - INS Vote Tally Sheet (Joint Favorable Substitute) (Y: 15 N: 4 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-03-11 | House | Filed with Legislative Commissioners' Office |
2020-03-10 | House | Joint Favorable Substitute |
2020-02-28 | House | Public Hearing 03/03 |
2020-02-27 | House | Referred to Joint Committee on Insurance and Real Estate |